Genetic influence of cytokine polymorphisms on the clinical outcome of Japanese gastrointestinal cancer patients in palliative care
- PMID: 30655809
- PMCID: PMC6313183
- DOI: 10.3892/ol.2018.9614
Genetic influence of cytokine polymorphisms on the clinical outcome of Japanese gastrointestinal cancer patients in palliative care
Abstract
Gastrointestinal cancer is one of the most common causes of mortality globally. The present study examined the influence of cytokine genetic polymorphisms [interleukin (IL)-1B C-31T, IL-1RN VNTR, IL-6 C-634G, IL-8 T-251A, IL-10 T-819C and IL-10 A-1082G] on clinical outcomes in patients with gastrointestinal cancer in palliative care. A total of 59 patients with gastrointestinal cancer who were admitted to Iga City General Hospital were analyzed. Genotyping was conducted using a polymerase chain reaction with confronting two-pair primers. Patients with at least one IL-1RN 2 allele demonstrated a significantly better survival (P=0.0275) while those with IL-6-634 G/G demonstrated a worse survival (P=0.0024). Multivariate analyses using the Cox proportional hazard model revealed that those with at least one IL-1RN 2 allele, IL-6-634 G/G or IL-10-1082 A/G had a significantly elevated adjusted hazard ratio of 9.20 (P=0.014), 41.01 (P=0.001) or 6.49 (P=0.046), respectively, compared with those with each homozygous wild-type polymorphism. In addition, the evaluation of weight loss by genotype revealed the potential influence of IL-10 T-819C genotype (P=0.072). IL-1RN, IL-6 and IL-10 polymorphisms were associated with the survival of patients with gastrointestinal cancer, suggesting the clinical feasibility of genetic testing in patients with gastrointestinal cancer in palliative care.
Keywords: cancer palliative care; cytokines; single nucleotide polymorphisms.
Figures



Similar articles
-
Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer.J Clin Oncol. 2005 Apr 1;23(10):2339-45. doi: 10.1200/JCO.2005.02.345. J Clin Oncol. 2005. PMID: 15800325 Clinical Trial.
-
IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population.Cancer Genet Cytogenet. 2008 Oct 15;186(2):63-8. doi: 10.1016/j.cancergencyto.2008.05.004. Cancer Genet Cytogenet. 2008. PMID: 18940468
-
[Relationship between interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms and susceptibility to gastric cancer].Zhonghua Yi Xue Za Zhi. 2002 May 25;82(10):685-8. Zhonghua Yi Xue Za Zhi. 2002. PMID: 12133467 Chinese.
-
PCR-CTPP: a new genotyping technique in the era of genetic epidemiology.Expert Rev Mol Diagn. 2001 May;1(1):119-23. doi: 10.1586/14737159.1.1.119. Expert Rev Mol Diagn. 2001. PMID: 11901796 Review.
-
Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer.World J Gastroenterol. 2010 Mar 14;16(10):1188-200. doi: 10.3748/wjg.v16.i10.1188. World J Gastroenterol. 2010. PMID: 20222161 Free PMC article. Review.
Cited by
-
Cancer cachexia as a multiorgan failure: Reconstruction of the crime scene.Front Cell Dev Biol. 2022 Sep 8;10:960341. doi: 10.3389/fcell.2022.960341. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36158184 Free PMC article. Review.
-
Interleukin 1 receptor antagonist gene variable number of tandem repeats polymorphism and cutaneous melanoma.Oncol Lett. 2019 Dec;18(6):5759-5768. doi: 10.3892/ol.2019.10923. Epub 2019 Sep 25. Oncol Lett. 2019. PMID: 31788049 Free PMC article.
References
-
- Toiyama Y, Miki C, Inoue Y, Tanaka K, Mohri Y, Kusunoki M. Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer. Exp Ther Med. 2011;2:95–101. doi: 10.3892/etm.2010.175. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous